Top 5 Highlights from AACR 2026

Top 5 Highlights from ASCO 2026

June 11, 2026

Sequential Erlotinib + Ramucirumab Before Osimertinib Does Not Improve Outcomes in EGFR L858R–Mutant NSCLC

June 1, 2026

Sunvozertinib Outperforms Chemotherapy in Frontline EGFR Exon 20 Insertion–Positive Advanced NSCLC

May 29, 2026

Amivantamab + Lazertinib Demonstrates Durable Survival in Atypical EGFR-Mutated Advanced NSCLC

May 29, 2026